Radiology Business Analytics Survey

Article

This four-question survey aims to gather information about radiologists’ views about and obstacles to collecting and analyzing operational data.

Business analytics can provide insights for radiology groups. With this four-question survey, I want to find any bottlenecks in collecting and analyzing the data. I'll write up a summary here after the survey closes.

 

Create your free online surveys with SurveyMonkey, the world's leading questionnaire tool.

 

The survey is also available here.

David Fuhriman is CEO of Bern Medical, a data specialist company. Bern provides dashboard reporting to iPad/iPhone, billing audits, and other data analysis services.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
Self-Interpretation of Imaging by Non-Radiologists Accounts for 43.5 Percent of Medicare Imaging Claims

Self-Interpretation of Imaging by Non-Radiologists Accounts for 43.5 Percent of Medicare Imaging Claims

Jeff Hall
April 3rd 2025
Article

In a review of over 1,630,000 office-based non-breast imaging Medicare fee-for-service (FFS) claims from 2022, researchers found that 39.5 percent of nuclear medicine imaging were interpreted by ordering clinicians.

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

Jeff Hall
March 18th 2025
Podcast

In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.

Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men

Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men

Jeff Hall
April 3rd 2025
Article

After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

Jeff Hall
September 1st 2023
Podcast

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

Breast MRI-Based Radiomics May Reduce Overtreatment of DCIS

Breast MRI-Based Radiomics May Reduce Overtreatment of DCIS

Jeff Hall
April 1st 2025
Article

New multicenter research suggests that radiomic features derived from breast MRI may enhance prognostic capabilities with disease upstaging for ductal carcinoma in situ (DCIS).

FDA Clears AZchest AI Software for New CXR Applications

FDA Clears AZchest AI Software for New CXR Applications

Jeff Hall
March 31st 2025
Article

The AI-powered AZchest CXR software reportedly offers 93.79 percent sensitivity and a 98.57 percent AUC for pneumothorax.

© 2025 MJH Life Sciences

All rights reserved.